CRTI Translational Research Grants

Objective

The objective of the CRTI Translational Research Grants is to partner Masonic Cancer Center basic/translational and clinical scientists so as to foster the development of novel experimental therapeutic agents and to facilitate their testing in institutional Phase I/II and IND clinical trials. These grants will provide targeted investments to promising translational studies with the goal of opening a clinical trial within 36 months.

Grant Program Contacts

All questions related to the application process, requirements, or eligibility should be directed to:
Jessica Raines-Jones
Research Development Coordinator
612-624-8679
mccgrant@umn.edu

Any questions regarding the applicability of research should be directed to:
Sarah Cooley, MD
cool0023@umn.edu

Previous Grantees

2018

Developing more effective regulatory T cell therapeutics using non-viral control of gene expression
Keli Hippen, PhD, Department of Pediatrics, Medical School
Bruce Blazar, MD, Department of Pediatrics, Medical School 

Endoglin, A Potential Novel Target for AML
Rita Perlingeiro, PhD, Department of Medicine, Medical School
Sarah Cooley, MD, Department of Medicine, Medical School

2017

Radioiodine-Based Therapy and Imaging for Pancreatic Cancer
Julia Davydova, MD, PhD, Department of Surgery, Medical School
Edward Greeno, MD, Department of Medicine, Medical School

Immune Response in Refractory Metastatic Melanoma Patients Undergoing Radiation Therapy
Evidio Domingo-Musibay, MD, Department of Medicine, Medical School
Heather Nelson, PhD, MPH, Department of Epidemiology and Community Health, School of Public Health 

2016

USP14 as an Independent Prognostic Biomarker and Therapeutic Target for Recurrent Endometrial Cancer
Martina Bazzaro, PhD, Department of Obstetrics, Gynecology and Women’s Health, Medical School
Melissa Geller, MD, Department of Obstetrics, Gynecology and Women’s Health, Medical School

IL-15 Superagonist ALT-803 for Treatment of Advanced Staged Ovarian Cancer
Melissa Geller, MD, Department of Obstetrics, Gynecology and Women’s Health, Medical School
Jeffrey Miller, MD, Department of Medicine, Medical School

eBAT (Epidermal Growth Factor Receptor (EGFR) Bispecific Angiotoxin) for the Treatment of EGFR Positive Malignancies
Brenda Weigel, MD, Department of Pediatrics, Medical School
Evidio Domingo-Musibay, MD, Department of Medicine, Medical School

Contact Us: 

Jessica Raines-Jones
Research Development Coordinator
612-624-8679
mccgrant@umn.edu

Elizabeth Fedie
Research Development Manager
612-624-0653
efedie@umn.edu 

David Largaespada, PhD
Associate Director for Basic Sciences

612-626-4979
larga002@umn.edu

Apply Here!